首页> 外文期刊>Acta Neurochirurgica >Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report.
【24h】

Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report.

机译:动脉内尼莫地平治疗创伤性蛛网膜下腔出血后的症状性脑血管痉挛。技术案例报告。

获取原文
获取原文并翻译 | 示例
           

摘要

Intra-arterial Nimodipine administration can be an effective alternative to papaverine or balloon angioplasty for the treatment of cerebral vasospasm refractory to medical therapy. It has been used for intractable vasospasm due to aneurysmal subarachnoid haemorrhage (SAH) with convincing results and no significant complications in small case series. This report describes of a patient with symptomatic and angiographically documented vasospasm following traumatic SAH which was refractory to maximal medical therapy and successfully treated with intra-arterial infusion of Nimodipine. This first reported technical note is with special reference to the nimodipine administration modalities, clinical and neuroradiological criteria of selection as well as the follow up of the patient.
机译:动脉内给予尼莫地平可以是罂粟碱或球囊血管成形术的有效替代品,用于治疗难治性药物的脑血管痉挛。由于动脉瘤性蛛网膜下腔出血(SAH),它已被用于顽固性血管痉挛,具有令人信服的结果,在小病例系列中无明显并发症。该报告描述了在创伤性SAH后有症状并通过血管造影记录的血管痉挛的患者,SAH对最大的药物治疗无效,并通过动脉内输注尼莫地平成功治疗。首次报道的技术说明特别涉及尼莫地平的给药方式,临床和神经放射学选择标准以及患者的随访情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号